Announcement of Hangzhou Tianmusan Pharmaceutical Co., Ltd. on receiving a notice of approval for drug re-registration

SZSI · Sep 13

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.